STS and breast carcinoma: Our results show that quercetin and known breast cancer drugs (ER antagonists, tamoxifen and fulvestrant, and STS inhibitor STX64) significantly inhibit MCF-7 cell proliferation in a concentration-dependent manner (Figure 4).